KOVARNIK, Tomas, Matsuo HITOSHI, Ales KRAL, Stepan JERABEK, David ZEMANEK, Yoshiaki KAWASE, Hiroyuki OMORI, Toru TANIGAKI, Jan PUDIL, Alexandra VODZINSKA, Marian BRANNY, Roman ŠTÍPAL, Petr KALA, Jan MROZEK, Martin PORZER, Tomas GREZL, Kamil NOVOBILSKY, Oscar MENDIZ, Karel KOPRIVA, Martin MATES, Martin CHVAL, Zhi CHEN, Pavel MARTASEK and Ales LINHART. Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study. Journal of the American Heart Association. Hoboken: Wiley-Blackwell, 2022, vol. 11, No 9, p. 1-17. ISSN 2047-9980. Available from: https://dx.doi.org/10.1161/JAHA.121.021490.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study
Authors KOVARNIK, Tomas (203 Czech Republic, guarantor), Matsuo HITOSHI, Ales KRAL (203 Czech Republic), Stepan JERABEK (203 Czech Republic), David ZEMANEK (203 Czech Republic), Yoshiaki KAWASE, Hiroyuki OMORI, Toru TANIGAKI, Jan PUDIL (203 Czech Republic), Alexandra VODZINSKA (203 Czech Republic), Marian BRANNY (203 Czech Republic), Roman ŠTÍPAL (203 Czech Republic, belonging to the institution), Petr KALA (203 Czech Republic, belonging to the institution), Jan MROZEK (203 Czech Republic), Martin PORZER (203 Czech Republic), Tomas GREZL (203 Czech Republic), Kamil NOVOBILSKY (203 Czech Republic), Oscar MENDIZ (203 Czech Republic), Karel KOPRIVA (203 Czech Republic), Martin MATES (203 Czech Republic), Martin CHVAL (203 Czech Republic), Zhi CHEN, Pavel MARTASEK (203 Czech Republic) and Ales LINHART (203 Czech Republic).
Edition Journal of the American Heart Association, Hoboken, Wiley-Blackwell, 2022, 2047-9980.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.400
RIV identification code RIV/00216224:14110/22:00129589
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1161/JAHA.121.021490
UT WoS 000789861900023
Keywords in English coronary flow reserve; fractional flow reserve; instantaneous wave-free ratio
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 27/1/2023 10:45.
Abstract
Background:The FiGARO (FFR versus iFR in Assessment of Hemodynamic Lesion Significance, and an Explanation of Their Discrepancies) trial is a prospective registry searching for predictors of fractional flow reserve/instantaneous wave-free ratio (FFR/iFR) discrepancy. Methods and Results:FFR/iFR were analyzed using a Verrata wire, and coronary flow reserve was analyzed using a Combomap machine (both Philips-Volcano). The risk polymorphisms for endothelial nitric oxide synthase and for heme oxygenase-1 were analyzed. In total, 1884 FFR/iFR measurements from 1564 patients were included. The FFR/iFR discrepancy occurred in 393 measurements (20.9%): FFRp (positive)/iFRn (negative) type (264 lesions, 14.0%) and FFRn/iFRp (129 lesions, 6.8%) type. Coronary flow reserve was measured in 343 lesions, correlating better with iFR (R=0.56, P<0.0001) than FFR (R=0.36, P<0.0001). The coronary flow reserve value in FFRp/iFRn lesions (2.24 +/- 0.7) was significantly higher compared with both FFRp/iFRp (1.39 +/- 0.36), and FFRn/iFRn lesions (1.8 +/- 0.64, P<0.0001). Multivariable logistic regression analysis confirmed (1) sex, age, and lesion location in the right coronary artery as predictors for FFRp/iFRn discrepancy; and (2) hemoglobin level, smoking, and renal insufficiency as predictors for FFRn/iFRp discrepancy. The FFRn/iFRp type of discrepancy was significantly more frequent in patients with both risk types of polymorphisms (endothelial nitric oxide synthase(r)+heme oxygenase-1(r)): 8 patients (24.2%) compared with FFRp/iFRn type of discrepancy: 2 patients (5.9%), P=0.03. Conclusions:Predictors for FFRp/iFRn discrepancy were sex, age, and location in the right coronary artery. Predictors for FFRn/iFRp were hemoglobin level, smoking, and renal insufficiency. The risk type of polymorphism in endothelial nitric oxide synthase and heme oxygenase-1 genes was more frequently found in patients with FFRn/iFRp type of discrepancy.
Links
TN01000013, research and development projectName: Personalizovaná medicína - diagnostika a terapie
Investor: Technology Agency of the Czech Republic, Personalized Medicine – Diagnostics and Therapy
PrintDisplayed: 21/8/2024 08:59